These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 8304048

  • 1. Determinants of remission of Paget's disease of bone.
    Patel S, Stone MD, Coupland C, Hosking DJ.
    J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD, Hawthorne AB, Kerr D, Webster G, Hosking DJ.
    J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bisphosphonate space measurement in Paget's disease of bone treated with APD.
    Stone MD, Marshall DH, Hosking DJ, Perkins AC, Evans AJ, Wastie ML.
    J Bone Miner Res; 1992 Mar; 7(3):295-301. PubMed ID: 1316715
    [Abstract] [Full Text] [Related]

  • 6. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
    Price RI, Gutteridge DH, Stuckey BG, Kent GN, Retallack RW, Prince RL, Bhagat CI, Johnston CA, Nicholson GC, Stewart GO.
    J Bone Miner Res; 1993 Feb; 8(2):209-17. PubMed ID: 8442439
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
    Harinck HI, Bijvoet OL, Blanksma HJ, Dahlinghaus-Nienhuys PJ.
    Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The treatment of Paget's disease of bone with second-generation bisphosphonates via intravenous infusion].
    Arboleya L, Sánchez J, Iglesias G, Arranz JL.
    Rev Clin Esp; 1993 Dec; 193(9):467-71. PubMed ID: 8108576
    [Abstract] [Full Text] [Related]

  • 11. Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH, Zwinderman AH, Vermeij P, Bijvoet OL, Papapoulos SE.
    J Bone Miner Res; 1993 Feb; 8(2):175-82. PubMed ID: 8442435
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of intravenous alendronate in Paget's disease of bone.
    O'Doherty DP, McCloskey EV, Vasikaran S, Khan S, Kanis JA.
    J Bone Miner Res; 1995 Jul; 10(7):1094-100. PubMed ID: 7484285
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
    Gutteridge DH, Retallack RW, Ward LC, Stuckey BG, Stewart GO, Prince RL, Kent GN, Bhagat CI, Price RI, Thompson RI, Nicholson GC.
    Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
    Vega E, Mautalen C, Roldán EJ, Pérez Lloret A.
    Drugs Exp Clin Res; 1994 Oct; 20(3):103-8. PubMed ID: 7956716
    [Abstract] [Full Text] [Related]

  • 18. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC, Charhon SA, Meunier PJ.
    Metab Bone Dis Relat Res; 1983 Oct; 4(6):325-8. PubMed ID: 6229683
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.